Phenbenzamine
Phenbenzamine (Antergan) is an antihistamine with anticholinergic properties.[1]
 | |
| Clinical data | |
|---|---|
| Trade names | Antergan |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider |
|
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H22N2 |
| Molar mass | 254.377 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
References
- "Phenbenzamine". Encyclopædia Britannica.
- US 2634293, Kyrides LP, Zienty FB, "Process of preparing a monobasic salt of a secondary amine", issued 7 April 1953, assigned to Monsanto Chemicals
- Kaye IA, Parris CL, Weiner N (1953). "A Novel N-Alkylation Reaction". Journal of the American Chemical Society. 75 (3): 744–745. doi:10.1021/ja01099a508.
| Benzimidazoles (*) | |
|---|---|
| Diarylmethanes |
|
| Ethylenediamines | |
| Tricyclics | |
| Others |
|
| For topical use | |
| H1 |
|
|---|---|
| H2 |
|
| H3 |
|
| H4 |
|
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.